Tekmira Pharmaceuticals Corporation logo
Exited company

Tekmira Pharmaceuticals Corporation

Details
Region
Prairies and West
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
Learn more
About the company

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira’s three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.